Rchr
J-GLOBAL ID:201901014625098633   Update date: May. 19, 2024

Maeda Takahiro

Maeda Takahiro
Affiliation and department:
Job title: 教授
Homepage URL  (2): https://precision.kyushu-u.ac.jphttps://precision.kyushu-u.ac.jp/en/
Research field  (1): Hematology and oncology
Research keywords  (2): Leukemia ,  Hematopoiesis
Research theme for competitive and other funds  (1):
  • 2020 - 2025 Development of novel therapeutic strategies for therapy-refractory leukemia
Papers (61):
  • Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, et al. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO Precision Oncology. 2024. 8
  • Yasunori Kogure, Handa H, Yuta Ito, Masaki Ri, Horigome Y, Iino M, Yoriko Harazaki, Takahiro Kobayashi, Masahiro Abe, Tadao Ishida, et al. ctDNA improves prognostic prediction in relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone. Blood. 2024
  • Sunami K, Naito Y, Saigusa Y, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Komine K, et al. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence. JAMA oncology. 2024
  • Horigome Y, Iino M, Harazaki Y, Kobayashi T, Handa H, Hiramatsu Y, Kuroi T, Tanimoto K, Matsue K, Abe M, et al. A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan. Annals of hematology. 2023
  • Takahiro Maeda. CELMoD for ALL: an exciting prospect. Blood. 2023
more...
MISC (2):
  • 山口 享子, 有山 寛, 吉弘 知恭, 土橋 賢司, 大内田 研宙, 長尾 吉泰, 副島 雄二, 草場 仁志, 前田 高宏, 中村 雅史, et al. Eカドヘリンの発現抑制は胃印環細胞癌特有の形態変化を誘導する(Loss of E-cadherin expression is the morphological determinant of human gastric signet ring cell carcinoma). 日本癌学会総会記事. 2018. 77回. 726-726
  • 中野 倫孝, 菊繁 吉謙, 鶴田 展大, 宮脇 恒太, 水野 晋一, 山口 享子, 山内 拓司, 土橋 賢司, 有山 寛, 草場 仁志, et al. CD168陽性細胞による大腸がん幹細胞の純化(CD168 expression marks a highly-concentrated human colorectal cancer stem cell population). 日本癌学会総会記事. 2018. 77回. 2101-2101
Education (2):
  • 1998 - 2001 名古屋大学大学院医学系研究科
  • 1988 - 1994 名古屋大学医学部
Work history (9):
  • 2020/03 - 現在 九州大学大学院医学研究院 プレシジョン医療学
  • 2016/10 - 2020/03 九州大学病院 遺伝子・細胞療法部
  • 2011/09 - 2016/09 Brigham and Women's Hospital
  • 2011/09 - 2016/09 Harvard Medical School
  • 2007/01 - 2011/08 Beckman Research Institute of the City of Hope
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page